logo

For the Inventor, By the Inventor

Cambridge, MA, United States of America

Marengo Therapeutics, Inc.

Calculating rank
USPTO Granted Patents = 13


Forward Citations = 24

Loading Chart...
Loading Chart...

14 inventors (with patents filed for the assignee):

goldMedal Andreas Loew (13 out of 51 patents)

silverMedal Brian Edward Vash (12 out of 18 patents)

bronzeMedal Jonathan Hsu (5 out of 6 patents)

4.  Stephanie J Maiocco (5 out of 5 patents)

5.  Seng-Lai Tan (5 out of 5 patents)

6.  Sangeetha Sagar Palakurthi (5 out of 5 patents)

7.  Dilini Charmain Gunasekera (4 out of 5 patents)

8.  Madan Katragadda (3 out of 10 patents)

9.  Nidhi Malhotra (3 out of 3 patents)

10.  Gurkan Guntas (2 out of 2 patents)

11.  Peter Marek (1 out of 1 patent)

12.  Peter Marek (1 out of 1 patent)

13.  Ilaria Lamberto (1 out of 1 patent)

14.  John Leonard Herrmann (1 out of 1 patent)


13 patents:

1. 12790395 - Multifunctional molecules that bind to T cell related cancer cells and uses thereof (2026-11-10),
2. 12421323 - Multispecific antibody molecules comprising lambda and kappa light chains (2025-09-23),
3. 12384842 - Antibody molecules that bind to NKP30 and uses thereof (2025-08-12),
4. 12358982 - Multifunctional molecules that bind to T cell related cancer cells and uses thereof (2025-07-15),
5. 12351632 - Anti-TCR antibody molecules and uses thereof (2025-07-08),
6. 12286477 - Anti-TCR antibody molecules and uses thereof (2025-04-29),
7. 12247060 - Calreticulin binding constructs and engineered T cells for the treatment of diseases (2025-03-11),
8. 12152073 - Multifunctional molecules that bind to calreticulin and uses thereof (2024-11-26),
9. 12134654 - Multispecific molecules and uses thereof (2024-11-05),
10. 11965025 - Method of treating solid cancers with bispecific interleukin-anti-TCRß molecules (2024-04-23),
11. 11845797 - Anti-TCR antibody molecules and uses thereof (2023-12-19),
12. 11673971 - Multispecific antibody molecules comprising lambda and kappa light chains (2023-06-13),
13. 11291721 - Multispecific and multifunctional molecules and uses thereof (2022-04-05),
Company Overview
Marengo Therapeutics, Inc. is a biotechnology company based in Cambridge, MA, focused on developing innovative therapies for cancer treatment. The organization specializes in harnessing the power of the immune system to create novel immuno-oncology solutions. By leveraging advanced research in cellular and molecular biology, Marengo aims to address unmet medical needs in oncology, striving to improve patient outcomes through targeted therapeutic approaches.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Nov 10 2026

13 Patents

#196 in Cambridge, MA

#1,449 in Massachusetts

#23,898 in US

#45,181 in the World

Cambridge, MA (US)
Cambridge, MA, United States of America

Marengo Therapeutics, Inc.

Forward Citations = 24

14 inventors:

goldMedal Andreas Loew (13 out of 51 patents)

silverMedal Brian Edward Vash (12 out of 18 patents)

bronzeMedal Jonathan Hsu (5 out of 6 patents)

4.  Stephanie J Maiocco (5 out of 5 patents)

5.  Seng-Lai Tan (5 out of 5 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Marengo Therapeutics, Inc.. Retrieved from https://idiyas.com/company/marengo-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…